ArticleNeurosurgical review2026
Artificial intelligence improves survival prediction in patients with brain metastases submitted to radiosurgery.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stereotactic radiosurgery (SRS) is effective for non-small cell lung cancer (NSCLC) brain metastases in deep or eloquent brain regions. Identifying predictors of treatment failure is crucial. Artificial intelligence (AI) models may improve prediction, but data on NSCLC BM are scarce. A retrospective study analyzed NSCLC patients with single brain metastases treated with SRS (Elekta Gamma Knife) from 2010 to 2015, with up to 10 years of follow-up. Clinical, radiological, and histological data were collected. Kaplan-Meier and Cox proportional hazards models assessed survival. Decision tree and random forest (RF) models predicted treatment failure, with feature importance analyzed. Among 133 patients (mean age 61.6, 56.4% male), most tumors were grade 1 (56.4%) and in the right hemisphere (60.2%). The mean tumor volume was 1.84 cm³. Decision trees identified metastasis volume and location as key predictors (AUC = 0.85). RF models improved prediction (AUC = 0.92). Tumor volume, diameter, and age were major predictors. AI models effectively identified patients at risk of treatment failure. A random forest based artificial intelligence model presented an excellent predictive ability for stereotactic radiosurgery success/failure in a population with NSCLC brain metastases, with an area under curve of 0.92. This predictive ability was superior to a decision tree or a simple diameter-to-volume ratio.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.